Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

De-noltab to be discontinued

The manufacturer of tripotassium dicitratobismuthate (De-noltab®) has written to healthcare professionals advising that the product will be discontinued with effect from the end of December 2015.

No reason for the decision to discontinue this product is provided in the letter. It is recommended that appropriate alternatives are discussed with any patient who is currently taking this medication as a long term treatment.

Action: Clinicians should be aware of this product being discontinued. It may be prudent to run clinical system searches to identify any patients who are currently prescribed this product to allow a review and an alternative to be arranged.

Share 'De-noltab to be discontinued' on Email Share 'De-noltab to be discontinued' on Delicious Share 'De-noltab to be discontinued' on Digg Share 'De-noltab to be discontinued' on Facebook Share 'De-noltab to be discontinued' on Google+ Share 'De-noltab to be discontinued' on reddit Share 'De-noltab to be discontinued' on StumbleUpon Share 'De-noltab to be discontinued' on Twitter

atomic-wealth

2 Comments to “De-noltab to be discontinued”

  1. I have a prescription but can't find the drug in Zambia. What alternative can I get?

    Comment by Daddy Chitalu — August 15, 2016 #
    Reply

    1. @Daddy,

      De-Noltab was used to treat gastric and duodenal ulcers. Proton pump inhibitors are the usual treatment in the UK - medicines like omeprazole and lansoprazole. You should probably discuss that wth your doctor though as they may not be suitable for everyone.

      Comment by Matthew Robinson — August 15, 2016 #
      Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,520 spam comments.

atomic-wealth
fond-illness
summer